Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results

by Business Wire • 2021/08/04 • 0 Comments

NEW YORK--(BUSINESS WIRE)--Iveric Bio announced financial and operating results for the quarter ended June 30, 2021 and provided a general business update.

Full Story →

← Start codon disruption with CRISPR-Cas9 gene editing prevents Fuchs’ corneal dystrophy in mice

Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa →

Post navigation